Current treatment options for craniofacial hyperhidrosis
Opções atuais de tratamento para hiperidrose craniofacial
Nelson Wolosker; Carolina Brito Faustino; Marcelo Fiorelli Alexandrino da Silva; José Ribas Milanez de Campos; Paulo Kauffman
Abstract
Keywords
Resumo
Resumo: A hiperidrose (HH) é caracterizada por transpiração além da quantidade necessária para manter a regulação térmica e as necessidades fisiológicas do corpo. Aproximadamente 9,41% dos indivíduos com HH apresentam hiperidrose craniofacial (FH). Este estudo tem como objetivo revisar os dados mais atuais da literatura sobre FH, incluindo fisiopatologia, diagnóstico e apresentação clínica, opções de tratamento (clínico e cirúrgico) e desfechos. A simpatectomia por videotoracoscopia (VATS) é considerada o padrão-ouro para o tratamento definitivo da hiperidrose axilar ou palmar. Recentemente, vários estudos demonstraram a utilidade do tratamento clínico com cloridrato de oxibutinina, que leva à melhora clínica da HH em mais de 70% dos pacientes. O tratamento clínico e o cirúrgico apresentam bons resultados no tratamento da FH. No entanto, o tratamento cirúrgico da FH apresenta mais complicações. O tratamento clínico com cloridrato de oxibutinina fornece bons resultados e pode ser a primeira opção terapêutica. Quando o paciente não está satisfeito com esse tratamento e mostra boas condições clínicas, o tratamento cirúrgico pode ser usado com segurança.
Palavras-chave
References
1 Cameron AEP. Selecting the right patient for surgical treatment of hyperhidrosis. Thorac Surg Clin. 2016;26(4):403-6.
2 Wolosker N, Campos JRM, Kauffman P, Oliveira LA, Munia MAS, Jatene FB. Evaluation of quality of life over time among 453 patients with hyperhidrosis submitted to endoscopic thoracic sympathectomy. J Vasc Surg. 2012;55(1):154-6.
3 Hornberger J, Grimes K, Naumann M, et al. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol. 2004;51(2):274-86.
4 Cerfolio RJ, Campos JRM, Bryant AS, et al. The Society of Thoracic Surgeons Expert Consensus for the Surgical Treatment of Hyperhidrosis. Ann Thorac Surg. 2011;91(5):1642-8.
5 Estevan FA, Wolosker MB, Wolosker N, Puech-Leão P. Epidemiologic analysis of prevalence of the hyperhidrosis. An Bras Dermatol. 2017;92(5):630-4.
6 Leiderman DBD, Campos JRM, Kauffman P, et al. The relation between age and outcomes of thoracic sympathectomy for hyperhidrosis: the older the better. J Thorac Cardiovasc Surg. 2018;156(4):1748-56.
7 Sato K, Kang WH, Saga K, Sato KT. Biology of sweat glands and their disorders. I. Normal sweat gland function. J Am Acad Dermatol. 1989;20(4):537-63.
8 Moura NB Jr, Neves-Pereira JC, Oliveira FR, et al. Expression of acetylcholine and its receptor in human sympathetic ganglia in primary hyperhidrosis. Ann Thorac Surg. 2013;95(2):465-70.
9 Adson AW. Essential hyperhidrosis cured by sympathetic ganglionectomy and trunk resection. Arch Surg. American Medical Association. 1935;31(5):794-806.
10 Adar R, Kurchin A, Zweig A, Mozes M. Palmar hyperhidrosis and its surgical treatment: a report of 100 cases. Ann Surg. 1977;186(1):34-41. PMid:879872.
11 Lyra RM, Campos JRM, Kang DWW, et al. Guidelines for the prevention, diagnosis and treatment of compensatory hyperhidrosis. J Bras Pneumol. 2008;34(11):967-77.
12 Byrne J, Walsh TN, Hederman WP. Endoscopic transthoracic electrocautery of the sympathetic chain for palmar and axillary hyperhidrosis. Br J Surg. 1990;77(9):1046-9. PMid:2131796.
13 Wenzel FG, Horn TD. Nonneoplastic disorders of the eccrine glands. J Am Acad Dermatol. 1998;38(1):1-17, quiz 18-20. PMid:9448199.
14 Chou SH, Kao EL, Lin CC, Chang YT, Huang MF. The importance of classification in sympathetic surgery and a proposed mechanism for compensatory hyperhidrosis: experience with 464 cases. Surg Endosc. 2006;20(11):1749-53. PMid:17024534.
15 Haider A, Solish N. Focal hyperhidrosis: diagnosis and management. CMAJ. 2005;172(1):69-75.
16 Teivelis MP, Wolosker N, Krutman M, Campos JRM, Kauffman P, Puech-Leão P. Compensatory Hyperhidrosis: Results of Pharmacologic Treatment With Oxybutynin. Ann Thorac Surg. 2014;98(5):1797-802.
17 Lembrança L, Wolosker N, Campos JRM, Kauffman P, Teivelis MP, Puech-Leão P. Videothoracoscopic Sympathectomy Results after Oxybutynin Chloride Treatment Failure. Ann Vasc Surg. 2017;43:283-7.
18 Wolosker N, Campos JRM, Kauffman P, Yazbek G, Neves S, Puech-Leão P. Use of oxybutynin for treating plantar hyperhidrosis. Int J Dermatol. 2013;52(5):620-3.
19 Wolosker N, Schvartsman C, Krutman M, et al. Efficacy and quality of life outcomes of oxybutynin for treating palmar hyperhidrosis in children younger than 14 years old. Pediatr Dermatol. 2014;31(1):48-53.
20 Wolosker N, Krutman M, Campdell TPDA, Kauffman P, Campos JRM, Puech-Leão P. Oxybutynin treatment for hyperhidrosis: a comparative analysis between genders. Einstein. 2012;10(4):405-8.
21 Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of the use of oxybutynin for the treatment of axillary hyperhidrosis. Ann Vasc Surg. 2014;28(5):1106-12.
22 Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of oxybutynin treatment for palmar hyperhidrosis. Clin Auton Res. 2014;24(6):297-303. PMid:25427685.
23 Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of oxybutynin use in treating facial hyperhidrosis. An Bras Dermatol. 2014;89(6):912-6.
24 Wolosker N, Krutman M, Kauffman P, Paula RP, Campos JRM, Puech-Leão P. Effectiveness of oxybutynin for treatment of hyperhidrosis in overweight and obese patients. Rev Assoc Med Bras. 2013;59(2):143-7.
25 Wolosker N, Teivelis MP, Krutman M, et al. Long-Term efficacy of oxybutynin for palmar and plantar hyperhidrosis in children younger than 14 years. Pediatr Dermatol. 2015;32(5):663-7.
26 Teivelis MP, Wolosker N, Krutman M, Kauffman P, Campos JRM, Puech-Leão P. Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin. Clinics (São Paulo). 2014;69(9):608-14.
27 Karlqvist M, Rosell K, Rystedt A, Hymnelius K, Swartling C. Botulinum toxin B in the treatment of craniofacial hyperhidrosis. J Eur Acad Dermatol Venereol. 2014;28(10):1313-7.
28 Cabreus P, Swartling C, Rystedt A. Postmenopausal craniofacial hyperhidrosis treated with botulinum toxin type B. J Dermatol. 2019;46(10):874-8.
29 Campos JRM, Kauffman P, Gomes O Jr, Wolosker N. Video-assisted thoracic sympathectomy for hyperhidrosis. Thorac Surg Clin. 2016;26(3):347-58.
30 Ishy A, Campos JRM, Wolosker N, et al. Objective evaluation of patients with palmar hyperhidrosis submitted to two levels of sympathectomy: T3 and T4. Interact Cardiovasc Thorac Surg. 2011;12(4):545-8.
31 Lin TS, Wang NP, Huang LC. Pitfalls and complication avoidance associated with transthoracic endoscopic sympathectomy for primary hyperhidrosis (analysis of 2200 cases). Int J Surg Investig. 2001;2(5):377-85. PMid:12678542.
32 Katara AN, Domino JP, Cheah W-K, So JB, Ning C, Lomanto D. Comparing T2 and T2-T3 ablation in thoracoscopic sympathectomy for palmar hyperhidrosis: a randomized control trial. Surg Endosc. 2007;21(10):1768-71.
33 Kim DH, Hong YJ, Hwang JJ, Kim KD, Lee DY. Topographical considerations under video-scope guidance in the T3,4 levels sympathetic surgery. Eur J Cardiothorac Surg. 2008;33(5):786-9.
34 Campos JRM, Wolosker N, Takeda FR, et al. The body mass index and level of resection: predictive factors for compensatory sweating after sympathectomy. Clin Auton Res. 2005;15(2):116-20.
35 Lin TS, Fang HY. Transthoracic endoscopic sympathectomy for craniofacial hyperhidrosis: analysis of 46 cases. J Laparoendosc Adv Surg Tech A. 2000;10(5):243-7.
36 Campos JRM, Kauffman P, Wolosker N, et al. Axillary hyperhidrosis: T3/T4 versus T4 thoracic sympathectomy in a series of 276 cases. J Laparoendosc Adv Surg Tech A. 2006;16(6):598-603.
37 Yazbek G, Wolosker N, Campos JRM, Kauffman P, Ishy A, Puech-Leão P. Palmar hyperhidrosis—which is the best level of denervation using video-assisted thoracoscopic sympathectomy: T2 or T3 ganglion? J Vasc Surg. 2005;42(2):281-5.
38 Teivelis MP, Varella AY, Wolosker N. Expanded level of sympathectomy and incidence or severity of compensatory hyperhidrosis. J Thorac Cardiovasc Surg. 2014;148(5):2443-4.
39 Ramsaroop L, Singh B, Moodley J, Partab P, Satyapal KS. Anatomical basis for a successful upper limb sympathectomy in the thoracoscopic era. Clin Anat. 2004;17(4):294-9. PMid:15108332.
40 Chung I-H, Oh C-S, Koh K-S, Kim H-J, Paik HC, Lee DY. Anatomic variations of the T2 nerve root (including the nerve of Kuntz) and their implications for sympathectomy. J Thorac Cardiovasc Surg. 2002;123(3):498-501.
41 Leão LEV, Oliveira R, Szulc R, Mari JJ, Crotti PLR, Gonçalves JJS. Role of video-assisted thoracoscopic sympathectomy in the treatment of primary hyperhidrosis. Sao Paulo Med J. 2003;121(5):191-7.
42 Andrade LO Fo, Kuzniec S, Wolosker N, Yazbek G, Kauffman P, Campos JRM. Technical difficulties and complications of sympathectomy in the treatment of hyperhidrosis: an analysis of 1731 cases. Ann Vasc Surg. 2013;27(4):447-53.
43 Wolosker N, Yazbek G, Campos JRM, et al. Quality of life before surgery is a predictive factor for satisfaction among patients undergoing sympathectomy to treat hyperhidrosis. J Vasc Surg. 2010;51(5):1190-4.
44 Campos JRM, Kauffman P, Werebe E C, et al. Questionnaire of quality of life in patients with primary hyperhidrosis. Jornal de Pneumologia. Sociedade Brasileira de Pneumologia e Tisiologia. 2003;29(4):178-81.
45 Campos JRM, Kauffman P, Werebe EC, et al. Quality of life, before and after thoracic sympathectomy: report on 378 operated patients. Ann Thorac Surg. 2003;76(3):886-91.
46 Hsu C-P, Shia SE, Hsia JY, Chuang CY, Chen CY. Experiences in Thoracoscopic Sympathectomy for Axillary Hyperhidrosis and Osmidrosis. Arch Surg. 2001;136(10):1115-7.
47 Lehrer E, Nogues A, Jaume F, Mullol J, Alobid I. Assessment of craniofacial hyperhidrosis and flushing by sphenopalatine blockade: a randomized trial. Rhinology. 2020;58(1):51-8. PMid:31475696.
Submitted date:
01/10/2020
Accepted date:
08/06/2020
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email